Genetic investigation into ethnic disparity in polycystic ovarian syndrome

References

• Solomon CG. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am 1999;28:247–63
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219–31
   PubMed Web of Science ®Google Scholar
• Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 2006;91:2100–4
   PubMed Web of Science ®Google Scholar
• Hague WM, Adams J, Reeders ST, et al. Familial polycystic ovaries: a genetic disease? Clin Endocrinol (Oxf) 1988;29:593–605
   PubMed Web of Science ®Google Scholar
• Lunde O, Magnus P, Sandvik L, Høglo S. Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest 1989;28:23–30
   PubMed Web of Science ®Google Scholar
• Kahsar-Miller MD, Nixon C, Boots LR, et al. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 2001;75:53–8
   PubMed Web of Science ®Google Scholar
• Legro RS, Driscoll D, Strauss JF 3rd, et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998;95:14956–60
   PubMed Web of Science ®Google Scholar
• Colilla S, Cox NJ, Ehrmann DA. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 2001;86:2027–31
   PubMed Web of Science ®Google Scholar
• Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome – a hypothesis. J Endocrinol 2002;174:1–5
   PubMed Web of Science ®Google Scholar
• Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol (Oxf) 2002;57:343–50
   PubMed Web of Science ®Google Scholar
• Carmina E, Legro RS, Stamets K, et al. Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod 2003;18:2289–93
   PubMed Web of Science ®Google Scholar
• Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745–9
   PubMed Web of Science ®Google Scholar
• Palep-Singh M, Picton HM, Vrotsou K, et al. South Asian women with polycystic ovary syndrome exhibit greater sensitivity to gonadotropin stimulation with reduced fertilization and ongoing pregnancy rates than their Caucasian counterparts. Eur J Obstet Gynecol Reprod Biol 2007;134:202–7
   PubMed Web of Science ®Google Scholar
• Glintborg D, Mumm H, Hougaard D, et al. Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark. Clin Endocrinol (Oxf) 2010;73:732–8
   PubMed Web of Science ®Google Scholar
• Guo M, Chen ZJ, Eijkemans MJ, et al. Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea. Hum Reprod 2012;27:1481–8
   PubMed Web of Science ®Google Scholar
• Ehrmann DA, Liljenquist DR, Kasza K, et al. PCOS/Troglitazone study group. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:48–53
   PubMed Web of Science ®Google Scholar
• Legro RS, Myers ER, Barnhart HX, et al. The Pregnancy in polycystic ovary syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 2006;86:914–33
   PubMed Web of Science ®Google Scholar
• Welt CK, Arason G, Gudmundsson JA, et al. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations. J Clin Endocrinol Metab 2006;91:4361–8
   PubMed Web of Science ®Google Scholar
• Li L, Yang D, Chen X, et al. Clinical and metabolic features of polycystic ovary syndrome. Int J Gynaecol Obstet 2007;97:129–34
   PubMed Web of Science ®Google Scholar
• Chen X, Yang D, Mo Y, et al. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol 2008;139:59–64
   PubMed Web of Science ®Google Scholar
• Hsu MI, Liou TH, Chou SY, et al. Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990. Fertil Steril 2007;88:727–9
   PubMed Web of Science ®Google Scholar
• Li S, Duan HM, Pang Z, et al. Heritability of endophenotypes related to metabolic diseases in Danish and Chinese twins: a cross population comparison. Obesity 2013 [Epub ahead of print]. doi: 10.1002/oby.20217
   Google Scholar
• Goodarzi MO. Looking for polycystic ovary syndrome genes: rational and best strategy. Semin Reprod Med 2008;26:5–13
   PubMed Web of Science ®Google Scholar
• Gharani N, Waterworth DM, Batty S, et al. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997;6:397–402
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Bartzis MI, Bergiele AT, et al. Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil Steril 2000;73:735–41
   PubMedGoogle Scholar
• Daneshmand S, Weitsman SR, Navab A, et al. Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters. Fertil Steril 2002;77:274–80
   PubMedGoogle Scholar
• Wang Y, Wu X, Cao Y, et al. A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome. Fertil Steril 2006;86:223–6
   PubMed Web of Science ®Google Scholar
• San Millán JL, Sancho J, Calvo RM, Escobar-Morreale HF. Role of the pentanucleotide (tttta)(n) polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertil Steril 2001;75:797–802
   PubMed Web of Science ®Google Scholar
• Gaasenbeek M, Powell BL, Sovio U, et al. Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab 2004;89:2408–13
   PubMedGoogle Scholar
• Tan L, Zhu G. Relationship between the microsatellite polymorphism of CYP11 alpha gene and the pathogenesis of hyperandrogenism of polycystic ovary syndrome in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005;22:216–18
   PubMedGoogle Scholar
• Urbanek M. The genetics of the polycystic ovary syndrome. Nat Clin Pract Endocrinol Metab 2007;3:103–11
   PubMedGoogle Scholar
• Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011;43:55–9
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhao H, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 2012;44:1020–5
   PubMed Web of Science ®Google Scholar
• Lerchbaum E, Trummer O, Giuliani A, et al. Susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in a cohort of Caucasian women. Horm Metab Res 2011;43:743–7
   PubMed Web of Science ®Google Scholar
• Eriksen MB, Brusgaard K, Andersen M, et al. Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis. Eur J Obstet Gynecol Reprod Biol 2012;163:39–42
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219–31
   PubMed Web of Science ®Google Scholar
• Odunsi K, Kidd KK. A paradigm for finding genes for a complex human trait: polycystic ovary syndrome and follistatin. Proc Natl Acad Sci USA 1999;96:8315–17
   PubMedGoogle Scholar
• Schellekens AF, Franke B, Ellenbroek B, et al. Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes. Arch Gen Psychiatry 2012;69:339–48
   PubMedGoogle Scholar
• Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: genetic interactions create phantom heritability. PNAS USA 2011;109:1193–8
   Google Scholar
• Yang J, Benyamin B, McEvoy BP, et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010;42:565–9
   PubMed Web of Science ®Google Scholar
• Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747–53
   PubMed Web of Science ®Google Scholar
• Metzker ML. Sequencing technologies – the next generation. Nat Rev Genetics 2010;11:31–46
   PubMed Web of Science ®Google Scholar
• Yan H, Yuan W, Velculescu VE, et al. Allelic variation in human gene expression. Science 2002;297:1143
   PubMed Web of Science ®Google Scholar
• Lo HS, Wang Z, Hu Y, et al. Allelic variation in gene expression is common in the human genome. Genome Res 2003;13:1855–62
   PubMed Web of Science ®Google Scholar
• Liu J, Hutchison K, Perrone-Bizzozero N, et al. Identification of genetic and epigenetic marks involved in population structure. PLoS One 2010;5:e13209
   PubMed Web of Science ®Google Scholar
• Zhang FF, Cardarelli R, Carroll J, et al. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics 2011;6:623–9
   PubMed Web of Science ®Google Scholar
• Spielman RS, Bastone LA, Burdick JT, et al. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 2007;39:226–31
   PubMed Web of Science ®Google Scholar
• Diao FY, Xu M, Hu Y, et al. The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. J Mol Endocrinol 2004;33:59–72
   PubMed Web of Science ®Google Scholar
• Jansen E, Laven JS, Dommerholt HB, et al. Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients. Mol Endocrinol 2004;18:3050–63
   PubMed Web of Science ®Google Scholar
• Wood JR, Nelson VL, Ho C, et al. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 2003;278:26380–90
   PubMed Web of Science ®Google Scholar
• Cortón M, Botella-Carretero JI, Benguría A, et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92:328–37
   PubMed Web of Science ®Google Scholar
• Wood JR, Dumesic DA, Abbott DH, Strauss JF 3rd. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 2007;92:705–13
   PubMed Web of Science ®Google Scholar
• Kenigsberg S, Bentov Y, Chalifa-Caspi V, et al. Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients. Mol Hum Reprod 2009;15:89–103
   PubMed Web of Science ®Google Scholar
• Qiao J, Wang L, Li R, Zhang X. Microarray evaluation of endometrial receptivity in Chinese women with polycystic ovary syndrome. Reprod Biomed Online 2008;17:425–35
   PubMed Web of Science ®Google Scholar
• Kim JY, Song H, Kim H, et al. Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2009;94:1416–26
   PubMed Web of Science ®Google Scholar
• Mohammed SI, Springfield S, Das R. Role of epigenetics in cancer health disparities. Methods Mol Biol 2012;863:395–410
   PubMedGoogle Scholar
• Li Z, Huang H. Epigenetic abnormality: a possible mechanism underlying the fetal origin of polycystic ovary syndrome. Med Hypotheses 2008;70:638–42
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Codner E, Pérez V, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009;94:1923–30
   PubMed Web of Science ®Google Scholar
• Qu F, Wang FF, Yin R, et al. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med (Berl) 2012;90:911–23
   PubMed Web of Science ®Google Scholar
• Nilsson E, Larsen G, Manikkam M, et al. Environmentally induced epigenetic transgenerational inheritance of ovarian disease. PLoS ONE 2012;7:e36129
   PubMed Web of Science ®Google Scholar
• Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond) 2008;32:1035–41
   PubMedGoogle Scholar
• Franks S, Berga SL. Does PCOS have developmental origins? Fertil Steril 2012;97:2–6
   PubMed Web of Science ®Google Scholar
• Xu N, Azziz R, Goodarzi MO. Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. Fertil Steril 2010;94:781–3
   PubMed Web of Science ®Google Scholar
• Tan Q, Christiansen L, Thomassen M, et al. Twins for epigenetic studies of human aging and development. Ageing Res Rev 2013;12:182–7
   PubMed Web of Science ®Google Scholar
• Lazar C, Meganck S, Taminau J, et al. Batch effect removal methods for microarray gene expression data integration: a survey. Brief Bioinform 2012. [Epub ahead of print]. doi: 10.1093/bib/bbs037
   Google Scholar